Company Filing History:
Years Active: 2019-2024
Title: The Innovations of Hans Fredrik Emtenâs
Introduction
Hans Fredrik Emtenâs is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical health conditions. With a total of 4 patents to his name, Emtenâs has established himself as a key figure in medical research and innovation.
Latest Patents
Among his latest patents, Emtenâs has developed pyrazole derivatives that serve as 5-lipoxygenase activating protein (FLAP) inhibitors. These novel compounds are designed to treat and prevent clinical conditions, including cardiovascular diseases (CVD). The applications detail methods for their therapeutic use, pharmaceutical compositions containing these compounds, and processes for their preparation.
Career Highlights
Emtenâs is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on innovative solutions that address pressing health issues, showcasing his commitment to improving patient outcomes through scientific advancements.
Collaborations
Throughout his career, Emtenâs has collaborated with esteemed colleagues, including Johan Olof Broddefalk and Kenneth Lars Granberg. These partnerships have further enhanced his research and development efforts, contributing to the success of his innovative projects.
Conclusion
Hans Fredrik Emtenâs exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in addressing critical health challenges.